Chembond Material Technologies share price & results
- Jun 2026
- Jun 2026
Navi Mumbai-based specialty-chemicals maker of automotive sealants, metal-treatment chemicals and engineering adhesives, plus animal-health/feed-additive biosciences products via its subsidiary.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 72.4 | +25.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 4.1 | −1.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 5.7 | +43.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 9.36 | −2.3 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | -2.02 | −9.5 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 24.49 | +11.5 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance +3.1% 1Y
1Y: ₹163.55 on 24 Oct 2025 → ₹168.67. High ₹225.82 (10 Sept 2026), low ₹106.72 (30 Mar 2026).
- Previous close
- ₹168.01
- Market cap
- ₹239 Cr
- 52-week range
- ₹106.72 – ₹225.82
- One year
- +2.64%
- Price to earnings (TTM to Jun 2026)
- 15.81×
- Return on equity (TTM to Jun 2026)
- 9.36%
Overview
- Symbol
- NSE:CHEMBOND
- Sector
- Chemicals
- Industry
- Commodities
- Exchange
- NSE
- Currency
- INR
What Chembond Material Technologies Limited does
Based on the company's own presentations, annual report and earnings calls.
Chembond Material Technologies manufactures specialty chemicals for the automotive, steel/general-engineering and industrial sectors -- automotive sealants (including paint-shop sealants and butyl tapes), metal treatment chemicals (phosphating, anodizing, protective and floor coatings) and engineering/structural adhesives. Through its subsidiary Chembond Biosciences Limited, the group also makes animal-health and industrial-biotech products -- probiotics, prebiotics & enzymes, biosecurity/farm-management solutions, feed additives and vitamin & mineral premixes -- sold into the poultry, dairy and aquaculture segments. The company operates four manufacturing plants in Maharashtra and exports select products (e.g., tack cloths, steel-treatment chemicals) to markets including Africa.
Segments
- Material Technologies
- Biosciences
- Manufacturing plants
- 4 (Alandi-Pune, Mahape, Rabale, Tarapur -- Maharashtra)
- Business segments
- 2 (Material Technologies; Biosciences)
- Subsidiaries
- 1 (Chembond Biosciences Limited)
- Quality/EHS certifications
- ISO 9001, ISO 14001, ISO 45001
- Years in operation
- 50 years (founded 1975)
- Export presence
- Steel-treatment chemicals and tack cloths exported to Africa and other international markets
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: +44% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 50 | 53 | 52 | 58 | 58 | 63 | 72 | 72 |
| Expenses | 47 | 49 | 49 | 54 | 54 | 59 | 65 | 69 |
| Operating profit | 3 | 4 | 4 | 3 | 4 | 4 | 6 | 3 |
| Operating margin | 5.6% | 7.1% | 6.9% | 6.0% | 7.0% | 6.6% | 9.0% | 4.1% |
| Other income | 5 | 0 | 2 | 3 | 0 | -0 | -1 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 7 | 3 | 4 | 5 | 3 | 3 | 4 | 6 |
| Tax rate | 11.2% | −4.2% | 25.2% | 25.7% | −34.4% | 46.5% | 19.9% | 1.7% |
| Net profit | 6 | 3 | 3 | 4 | 4 | 2 | 3 | 6 |
| EPS (₹ per share) | 4.69 | 2.42 | 2.51 | 2.98 | 2.86 | 1.19 | 2.60 | 4.28 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 440 | 387 | 201 | 250 |
| Expenses | 406 | 347 | 188 | 232 |
| Operating profit | 35 | 41 | 14 | 18 |
| Other income | 5 | 17 | 9 | 1 |
| Interest | 1 | 1 | 1 | 0 |
| Depreciation | 5 | 5 | 3 | 4 |
| Profit before tax | 34 | 51 | 19 | 16 |
| Net profit | 25 | 39 | 18 | 13 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 297 | 315 | 137 | 149 | 155 | 160 |
| Borrowings | 2 | 7 | 7 | 3 | 6 | 4 |
| Other liabilities | 56 | 74 | 41 | 43 | 44 | 48 |
| Total liabilities | 361 | 402 | 191 | 202 | 211 | 219 |
| Fixed assets | 121 | 116 | 26 | 34 | 41 | 41 |
| Capital work in progress | 1 | 12 | 13 | 8 | 1 | 2 |
| Investments | 75 | 65 | 65 | 78 | 68 | 70 |
| Other assets | 165 | 208 | 87 | 83 | 101 | 107 |
| Total assets | 361 | 402 | 191 | 202 | 211 | 219 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 25 | -10 | 1 | 94 | 19 | 15 |
| Cash from investing | -11 | -2 | 1 | -89 | -8 | -10 |
| Cash from financing | -2 | -4 | -2 | -5 | -9 | -1 |
| Net cash flow | 12 | -16 | 0 | 0 | 2 | 3 |
| Free cash flow | 22 | -14 | -12 | 90 | 16 | -5 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 111 | 94 | 96 | 100 | 72 | 77 |
| Inventory days | 82 | 67 | 53 | 58 | 56 | 54 |
| Days payable | 120 | 76 | 81 | 118 | 113 | 95 |
| Cash conversion cycle | 73 | 84 | 67 | 40 | 15 | 36 |
| Working capital days | 83 | 78 | 70 | 39 | 25 | 47 |
| Return on capital employed | 10.0% | 7.0% | 10.0% | 5.0% | 12.0% | 11.0% |
| Dividend payout | 15.0% | 48.0% | 16.0% | 42.0% | 13.0% | 21.0% |
Where revenue comes from
The businesses behind the company’s reported revenue.
Specialty Chemical contributes 85.7% of reported segment revenue.
Quarter ended 30 Jun 2026 · Consolidated
- Specialty Chemical 85.7%
₹62.05 crore
- Animal Health 14.3%
₹10.36 crore
| Business segment | Revenue · ₹ crore | Share |
|---|---|---|
| Specialty Chemical | 62.05 | 85.7% |
| Animal Health | 10.36 | 14.3% |
Share = segment revenue ÷ total segment revenue, before intersegment adjustments.
How these numbers add up
- Total segment revenue
- ₹72.42 crore
- Intersegment adjustment
- Not reported
- Net segment revenue
- ₹72.42 crore
Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.
Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.
How the mix has moved
Animal Health shrank from 17% to 14% of revenue over the last five quarters.
| Segment | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Jun 2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|
| Specialty Chemical | — | — | 83% | — | 86% | — |
| Animal Health | 17% | 17% | 17% | 18% | 14% | +7.8% |
Share of reported segment revenue by quarter, consolidated basis, as filed. A quarter the company did not report is left blank, never carried forward.
See how segments are shifting across companies → Segment Shift
What the price assumes
Growth trapTo justify its price of ₹169, this stock must grow earnings at 10% every year for 7 years. Our analysis caps realistic growth at ~-20%. At that growth it is worth ₹34 — downside of 80%.
- Growth the price implies
- 9.6% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -19.7% a year
- net profit, FY23–FY26 · EPS -19.6%
- The gap
- 0.3 pp
- -80% downside if it only repeats history
Ownership
Who owns it
Promoters hold 68.11% as of Jun 2026; institutions added 0.88 pts since Mar 2026.
- Promoters 68.11%
- Foreign institutions 0.61%
- Domestic institutions 1.62%
- Public 29.68%
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- AIF newly disclosed 1.19% held
- +0.18 pp 1.82% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Chembond Material Technologies Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| 27.36% | unchanged | |
| 12.57% | unchanged | |
| 9.75% | unchanged | |
| 3.72% | unchanged | |
| 3.72% | unchanged | |
| 2.04% | unchanged | |
| 2.03% | unchanged | |
| 1.95% | unchanged | |
| 1.82% | +0.18 pp | |
| 1.40% | unchanged | |
| AIF | 1.19% | newly disclosed |
| 0.97% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Chembond Material Technologies Limited
Free account: one company. Everything above stays public.
Write why you follow Chembond Material Technologies Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Chemicals companies
Learn to analyse Chembond Material Technologies Limited
Guides on how to read this kind of business and the numbers that matter.